StonvexLoading…
StonvexStonvexStonvexCore line items from VTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $273.99M | $242.00M | $233.91M | $281.89M |
Operating Income | $17.13M | $40.97M | $34.85M | $153.87M |
Net Income | $25.28M | $21.06M | $-19.74M | $118.90M |
EPS (Diluted) | $0.64 | $0.64 | $-0.73 | $0.26 |
Total Assets | $893.35M | $810.89M | $765.97M | $660.48M |
Total Liabilities | $264.03M | $310.56M | $219.56M | $91.50M |
Cash & Equivalents | $1.33M | $2.97M | $552.00K | $10.01M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 39.55M | 32.91M | 29.56M | 438.63M |